Aventura Private Wealth’s AbbVie ABBV Stock Holding History

Aventura Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Buy	9,370 +9	+0.1%	+$1.94K	0.72%	27
2026 Q1	$2.04M	Sell	9,361 -3	-0%	-$665	0.74%	23
2025 Q4	$2.14M	Sell	9,364 -114	-1%	-$26K	0.77%	23
2025 Q3	$2.19M	Buy	9,478 +201	+2%	+$40.9K	0.81%	22
2025 Q2	$1.72M	Sell	9,277 -227	-2%	-$42.2K	0.75%	26
2025 Q1	$1.99M	Buy	9,504 +470	+5%	+$91.4K	1.04%	14
2024 Q4	$1.61M	Buy	+9,034	New	+$1.66M	0.86%	19

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aventura Private Wealth's ABBV Position: Q2 2026 in Review

Aventura Private Wealth increased its AbbVie (ABBV) stake by 0.1% in Q2 2026, buying an estimated $1.94K and bringing the position to 9,370 shares worth $2.36M. The position accounts for 0.72% of the portfolio, ranked #27.

Aventura Private Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Aventura Private Wealth held 9,370 shares of AbbVie worth $2.36M as of Q2 2026.
Aventura Private Wealth bought 9 AbbVie shares in Q2 2026, an estimated $1.94K.
AbbVie made up 0.72% of Aventura Private Wealth's portfolio in Q2 2026, its #27 holding.
Aventura Private Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.